BioRestorative Therapies
BRTX
15 hedge funds and large institutions have $412K invested in BioRestorative Therapies in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.
7% more funds holding
Funds holding: 14 → 15 (+1)
0.78% less ownership
Funds ownership: 4.07% → 3.3% (-0.78%)
18% less capital invested
Capital invested by funds: $502K → $412K (-$89.4K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$20.9K |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$5.21K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$26 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
-$23.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.96K |
| 4 |
Morgan Stanley
New York
|
-$5.21K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.33K |
BRTX Hedge Fund Activity: Q2 2025 in Review
15 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2025, worth a combined $412K — down 18% from $502K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BRTX positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $20.9K. The largest seller was StoneX Group, cutting an estimated $23.4K.
- 15 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2025, up from 14 in Q1 2025.
- Funds reported $412K of BioRestorative Therapies stock for Q2 2025, down 18% quarter-over-quarter.
- 2 funds opened new BioRestorative Therapies positions in Q2 2025 and 0 closed out, a net change of +2 holders.
- The largest BioRestorative Therapies buyer in Q2 2025 was Virtu Financial, an estimated $20.9K added.
- The largest BioRestorative Therapies seller in Q2 2025 was StoneX Group, an estimated $23.4K sold.
Based on aggregated 13F filings for Q2 2025.